1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Drivers 4.3 Restraints 4.4 Porter's Five Forces Analysis 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Consumers 4.4.3 Threat of New Entrants 4.4.4 Threat of Substitute Products and Services 4.4.5 Intensity of Competitive Rivalry 5 Market Segmentation 5.1 By Product (Value and Volume, 2012-2024) 5.1.1 Cartridges in Reusable Insulin Pens 5.1.2 Disposable Insulin Pens 5.1.3 Insulin Syringes 5.1.4 Insulin Jet Injectors 5.1.5 Insulin Pump 5.1.5.1 Insulin Pump Device 5.1.5.2 Insulin Pump Reservoir 5.1.5.3 Infusion Set 5.2 Geography 5.2.1 Asia-Pacific (Value and Volume, 2012-2024) 5.2.1.1 Australia 5.2.1.2 India 5.2.1.3 Indonesia 5.2.1.4 Thailand 5.2.1.5 Philippines 5.2.1.6 Vietnam 5.2.1.7 China 5.2.1.8 South Korea 5.2.1.9 Japan 5.2.1.10 Malaysia 5.2.1.11 Rest of Asia-Pacific 6 COMPETITIVE LANDSCAPE 6.1 Becton and Dickenson 6.2 Medtronic 6.3 Insulet 6.4 Tandem 6.5 Ypsomed 6.6 Novo Nordisk 6.7 Sanofi 6.8 Eli Lilly 7 MARKET OPPORTUNITIES AND FUTURE TRENDS

- Becton and Dickenson - Medtronic - Insulet - Tandem - Ypsomed - Novo Nordisk - Sanofi - Eli Lilly